{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:29:14Z","timestamp":1783384154005,"version":"3.54.6"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0902800"],"award-info":[{"award-number":["2016YFC0902800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFA0104502"],"award-info":[{"award-number":["2017YFA0104502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017ZX09304021"],"award-info":[{"award-number":["2017ZX09304021"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017703","name":"Innovation Capability Development Project of Jiangsu Province","doi-asserted-by":"publisher","award":["BM2015004"],"award-info":[{"award-number":["BM2015004"]}],"id":[{"id":"10.13039\/501100017703","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Key Medical Center","award":["YXZXA2016002"],"award-info":[{"award-number":["YXZXA2016002"]}]},{"name":"Jiangsu Medical Outstanding Talents Project","award":["JCRCA2016002"],"award-info":[{"award-number":["JCRCA2016002"]}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Science Foundation of Suzhou","award":["No.SKY2021040"],"award-info":[{"award-number":["No.SKY2021040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00277-024-05910-w","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T04:15:27Z","timestamp":1722485727000},"page":"3483-3491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence"],"prefix":"10.1007","volume":"103","author":[{"given":"Xiaoli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"issue":"17","key":"5910_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young NS (2018) Aplastic anemia. N Engl J Med 379(17):1643\u20131656","journal-title":"N Engl J Med"},{"issue":"2","key":"5910_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JC (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187\u2013207. https:\/\/doi.org\/10.1111\/bjh.13853","journal-title":"Br J Haematol"},{"issue":"15","key":"5910_CR3","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/bloodadvances.2018021162","volume":"2","author":"GE Georges","year":"2018","unstructured":"Georges GE, Doney K, Storb R (2018) Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv 2(15):2020\u20132028. https:\/\/doi.org\/10.1182\/bloodadvances.2018021162","journal-title":"Blood Adv"},{"key":"5910_CR4","doi-asserted-by":"publisher","first-page":"100772","DOI":"10.1016\/j.blre.2020.100772","volume":"47","author":"R Iftikhar","year":"2021","unstructured":"Iftikhar R, Chaudhry QUN, Anwer F, Neupane K, Rafae A, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, Khattak TA, Shamshad GU, Rehman J, Farhan M, Khan M, Ansar I, Ashraf R, Marsh J, Satti TM, Ahmed P (2021) Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies. Blood Rev 47:100772. https:\/\/doi.org\/10.1016\/j.blre.2020.100772","journal-title":"Blood Rev"},{"key":"5910_CR5","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","volume":"85","author":"SJ Rosenfeld","year":"1995","unstructured":"Rosenfeld SJ, Kimball J, Vining D, Young NS (1995) Intensive immunosuppression with antithymocyte glovulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85:3058\u20133065","journal-title":"Blood"},{"key":"5910_CR6","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, Young NS (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med 365:430\u2013438. https:\/\/doi.org\/10.1056\/NEJMoa1103975","journal-title":"N Engl J Med"},{"issue":"6","key":"5910_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS (2012) How I treat acquired aplastic anemia. Blood 120(6):1185\u20131196. https:\/\/doi.org\/10.1182\/blood-2011-12-274019","journal-title":"Blood"},{"issue":"6","key":"5910_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/bjh.17403","volume":"194","author":"P Scheinberg","year":"2021","unstructured":"Scheinberg P (2021) Acquired severe aplastic anemia: how medical therapy evolved in the 20th and 21st centuries. Br J Haematol 194(6):954\u2013969. https:\/\/doi.org\/10.1111\/bjh.17403","journal-title":"Br J Haematol"},{"issue":"3","key":"5910_CR9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/j.seminhematol.2007.04.010","volume":"44","author":"JC Marsh","year":"2007","unstructured":"Marsh JC, Ganser A, Stadler M (2007) Hematopoietic growth factors in the treatment of acquired bone marrow failure states. Semin Hematol 44(3):138\u2013147. https:\/\/doi.org\/10.1053\/j.seminhematol.2007.04.010","journal-title":"Semin Hematol"},{"key":"5910_CR10","doi-asserted-by":"publisher","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu1 B, Rios1 O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Younget NS (2017) Eltrombopag added to standard immunosuppression for aplastic anemia. N Engl J Med 376(16):1540\u20131550. https:\/\/doi.org\/10.1056\/NEJMoa1613878","DOI":"10.1056\/NEJMoa1613878"},{"key":"5910_CR11","doi-asserted-by":"publisher","unstructured":"Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, R de Groot m, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, Rocca UL, Sureda A, S\u00e1nchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, de Sicre F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, Lint MT, Passweg JR, Marsh JCW, Soci\u00e9 G, Mufti GJ, Dufour C, Risitano AM (2022) Eltrombopag added to immunosuppression in severe aplastic anemia. N Engl J Med 386(1):11\u201323. https:\/\/doi.org\/10.1056\/NEJMoa2109965","DOI":"10.1056\/NEJMoa2109965"},{"issue":"2","key":"5910_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"SB Killick","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JCW (2016) Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol 172(2):187\u2013207. https:\/\/doi.org\/10.1111\/bjh.13853","journal-title":"Br J Haematol"},{"issue":"9","key":"5910_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jtct.2022.05.027","volume":"28","author":"LF Huang","year":"2022","unstructured":"Huang LF, Li L, Jia JS, Yang Y, Lin SY, Meng FK, Zhang DH, He GS (2022) Frontline therapy options for adults with newly diagnosed severe aplastic anemia: intensive immunosuppressive therapy plus eltrombopag or matched sibling donor hematopoietic stem cell transplantation? Transpl Cell Ther 28(9):586.e1-586.e7","journal-title":"Transpl Cell Ther"},{"issue":"12","key":"5910_CR14","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3324\/haematol.2014.109355","volume":"99","author":"N Yoshida","year":"2014","unstructured":"Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe KI, Kudo K, Morimoto A, Ohga S, Muramatsu H, Takahashi Y, Kato K, Suzuki R, Ohara A, Kojima S (2014) First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haematologica 99(12):1784\u20131791. https:\/\/doi.org\/10.3324\/haematol.2014.109355","journal-title":"Haematologica"},{"issue":"12","key":"5910_CR15","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1038\/s41375-020-0933-7","volume":"34","author":"L Limin","year":"2020","unstructured":"Limin L, Yanming Z, Wenjing J, Huifen Z, Qingyuan W, Song J, Yifeng C, Liyun Z, Xiaohui S, Zefa L, Jinge X, Meiqing L, Xiaoyun Y, Miao M, Depei W (2020) Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia. Leukemia 34(12):3359\u20133369. https:\/\/doi.org\/10.1038\/s41375-020-0933-7","journal-title":"Leukemia"},{"issue":"6","key":"5910_CR16","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1345\/aph.1P042","volume":"44","author":"SL Corman","year":"2010","unstructured":"Corman SL, Mohammad RA (2010) Eltrombopag: a novel oral thrombopoietin receptor agonist. Ann Pharmacother 44(6):1072\u20131079. https:\/\/doi.org\/10.1345\/aph.1P042","journal-title":"Ann Pharmacother"},{"issue":"6481","key":"5910_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/369568a0","volume":"369","author":"K Kaushansky","year":"1994","unstructured":"Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369(6481):568\u2013571. https:\/\/doi.org\/10.1038\/369568a0","journal-title":"Nature"},{"issue":"19","key":"5910_CR18","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1182\/blood-2018-11-884486","volume":"133","author":"LJ Alvarado","year":"2019","unstructured":"Alvarado LJ, Huntsman HD, Cheng H, Townsley DM, Winkler T, Feng X, Dunbar CE, Young NS, Larochelle A (2019) Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-\u03b3. Blood 133(19):2043\u20132055. https:\/\/doi.org\/10.1182\/blood-2018-11-884486","journal-title":"Blood"},{"issue":"2","key":"5910_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.scr.2012.05.001","volume":"9","author":"H Sun","year":"2012","unstructured":"Sun H, Tsai Y, Nowak I, Liesveld J, Chen Y (2012) Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem\/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis. Stem Cell Res 9(2):77\u201386. https:\/\/doi.org\/10.1016\/j.scr.2012.05.001","journal-title":"Stem Cell Res"},{"issue":"17","key":"5910_CR20","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1182\/blood-2016-10-740241","volume":"130","author":"E Vlachodimitropoulou","year":"2017","unstructured":"Vlachodimitropoulou E, Chen YL, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J (2017) Eltrombopag: a powerful chelator of cellular or extracellular iron alone or combined with a second chelator. Blood 130(17):1923\u20131933. https:\/\/doi.org\/10.1182\/blood-2016-10-740241","journal-title":"Blood"},{"issue":"Suppl 1","key":"5910_CR21","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1053\/j.seminhematol.2016.04.010","volume":"53","author":"A Schifferli","year":"2016","unstructured":"Schifferli A, Kuhne T (2016) Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia? Semin Hematol 53(Suppl 1):S31\u201334. https:\/\/doi.org\/10.1053\/j.seminhematol.2016.04.010","journal-title":"Semin Hematol"},{"issue":"6","key":"5910_CR22","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s10238-023-00989-3","volume":"23","author":"R Li","year":"2023","unstructured":"Li R, Wang N, Chai X, Yang L, Liu K, He H, Lin S, Yang Y, Jia J, Zhang D, Gong Y, Shi J, He G, Li J (2023) Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world. Clin Exp Med 23(6):2619\u20132627. https:\/\/doi.org\/10.1007\/s10238-023-00989-3","journal-title":"Clin Exp Med"},{"issue":"2","key":"5910_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3324\/haematol.2017.176339","volume":"103","author":"E Lengling","year":"2018","unstructured":"Lengling E, Drenou B, Peterlin P, Tournilhac O, Abraham J, Berceanu A, Dupriez B, Guillerm G, Raffoux E, Sicre de Fontbrune F, Ades L, Balsat M, Chaoui D, Coppo P, Corm S, Leblanc T, Maillard N, Terriou L, Soci\u00e9 G, de Peffault R (2018) Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia. Haematologica 103(2):212\u2013220. https:\/\/doi.org\/10.3324\/haematol.2017.176339","journal-title":"Haematologica"},{"issue":"8","key":"5910_CR24","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2169\/internalmedicine.6063-20","volume":"60","author":"K Imada","year":"2021","unstructured":"Imada K, Obara N, Iida H, Imajo K, Maeda T, Usuki K, Fanghong Z, Hombo Y, Tajima T, Kumagai A, Matsuda A, Nakao S (2021) Eltrombopag in combination with rabbit anti-thymocyte globulin\/cyclosporine A in immunosuppressive therapy-naive patients with aplastic anemia in Japan. Intern Med 60(8):1159\u20131168. https:\/\/doi.org\/10.2169\/internalmedicine.6063-20","journal-title":"Intern Med"},{"issue":"11","key":"5910_CR25","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s00277-017-3086-7","volume":"96","author":"EH Atta","year":"2017","unstructured":"Atta EH, Lima C, Dias D, Cl\u00e9 DV, Bonduel MM, Sciuccati GB, Medeiros LA, Oliveira MM, Salvino MA, Garanito MP, Fonseca PBB, Saad STO, Calado RT, Scheinberg P (2017) Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia. Ann Hematol 96(11):1907\u20131914. https:\/\/doi.org\/10.1007\/s00277-017-3086-7","journal-title":"Ann Hematol"},{"key":"5910_CR26","first-page":"669","volume":"50","author":"A Gaman","year":"2009","unstructured":"Gaman A, Gaman G, Bold A (2009) Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors. Rom J Morphol Embryol 50:669\u2013674","journal-title":"Rom J Morphol Embryol"},{"issue":"9","key":"5910_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","volume":"289","author":"S Rosenfeld","year":"2003","unstructured":"Rosenfeld S, Follmann D, Nunez O, Young NS (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289(9):1130\u20131135. https:\/\/doi.org\/10.1001\/jama.289.9.1130","journal-title":"JAMA"},{"issue":"3","key":"5910_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12185-020-02955-1","volume":"112","author":"L Ye","year":"2020","unstructured":"Ye L, Zhang F, Kojima S (2020) Current insights into the treatments of severe aplastic anemia. Int J Hematol 112(3):292\u2013299. https:\/\/doi.org\/10.1007\/s12185-020-02955-1","journal-title":"Int J Hematol"},{"issue":"8","key":"5910_CR29","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41409-020-0820-x","volume":"55","author":"SH Shin","year":"2020","unstructured":"Shin SH, Park SS, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Lee JW (2020) Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired aplastic anemia. Bone Marrow Transpl 55(8):1570\u20131579. https:\/\/doi.org\/10.1038\/s41409-020-0820-x","journal-title":"Bone Marrow Transpl"},{"key":"5910_CR30","doi-asserted-by":"publisher","first-page":"714033","DOI":"10.3389\/fonc.2021.714033","volume":"11","author":"L Meiqing","year":"2022","unstructured":"Meiqing L, Xiaoli L, Yanming Z, Qi Q, Wenjing J, Huifen Z, Qingyuan W, Huiying Q, Xiaowen T, Yue H, Chengcheng F, Zhengming J, Suning C, Aining S, Miao M, Limin L, Depei W (2022) Comparable outcomes and health-related quality of life for severe aplastic anemia: haploidentical combined with a single cord blood unit vs matched related transplants. Front Oncol 11:714033. 10.3389.11:714033","journal-title":"Front Oncol"},{"key":"5910_CR31","doi-asserted-by":"publisher","first-page":"955095","DOI":"10.3389\/fimmu.2022.955095","volume":"13","author":"L Limin","year":"2022","unstructured":"Limin L, Miao M, Hailong H, Shunqing W, Yanming Z, Ailian G, Wenjing J, Meiqing L, Yifeng C, Xiaohui S, Zefa L, Jinge X, Xiaoli L, Liansheng Z, Depei W (2022) Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: long-term outcomes of a multicenter study. Front Immunol 13:955095. https:\/\/doi.org\/10.3389\/fimmu.2022.955095","journal-title":"Front Immunol"},{"issue":"1","key":"5910_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","volume":"11","author":"L Xu","year":"2018","unstructured":"Xu L, Chen H, Chen J, Han M, Huang H, Lai Y, Liu D, Liu Q, Liu T, Jiang M, Ren H, Song Y, Sun Z, Wang J, Wu D, Zhou D, Zou P, Liu K, Huang X (2018) The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China. Recommendations from the Chinese Society of Hematology. J Hematol Oncol 11(1):33. https:\/\/doi.org\/10.1186\/s13045-018-0564-x","journal-title":"J Hematol Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05910-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:19:13Z","timestamp":1724836753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05910-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5910"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05910-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by institutional review boards and independent ethics committees at each center (leading ethics committee: ethics committee at the First Affiliated Hospital of Soochow University) and conducted in accordance with the Declaration of Helsinki. All patients or their guardians signed a written, informed consent at study inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors review the manuscript and agree to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}